Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report.
M K
MK
Pilhatsch
R
R
Burghardt
K-P
KP
Wandinger
M
M
Bauer
M
M
Adli
D000069445:Atomoxetine Hydrochloride; D003024:Clozapine / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D009661:Nortriptyline / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000150:complications*; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D012720:Severity of Illness Index
D000069445:Atomoxetine Hydrochloride; D003024:Clozapine; D009661:Nortriptyline; D011437:Propylamines; D017367:Selective Serotonin Reuptake Inhibitors